TELA
TELA
NASDAQ · Health Care

Tela Bio Inc

$0.64
-0.03 (-4.97%)
As of Aug 15, 2:27 AM ET ·
Financial Highlights (FY 2026)
Revenue
83.04M
Net Income
-40,169,671
Gross Margin
67.7%
Profit Margin
-48.4%
Rev Growth
+24.7%
D/E Ratio
8.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 83.04M 66.61M 7.47M 7.60M
Gross Profit 56.21M 45.09M 2.11M 2.15M
Operating Income -35,842,014 -25,872,483 1.36M 1.26M
Net Income -40,169,671 -28,996,393 1.27M 1.28M
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Rev Growth +24.7% +24.7% +18.1% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 14.05M 14.05M 9.64M 8.55M
Total Equity 1.59M 1.59M 26.51M 24.38M
D/E Ratio 8.82 8.82 0.36 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -35,186,709 -26,810,533 2.01M 2.00M
Free Cash Flow 1.14M 1.46M